FDA is expected to issue guidance for biosimilars this year

05/9/2011 | Reuters · Hill, The

The FDA likely will release this year a set of guidelines for drugmakers applying for market approval of biogenerics, said Janet Woodcock, head of the agency's Center for Drug Evaluation and Research. The FDA is "meeting with companies individually right now and giving them advice on their programs," and the agency is "very interested in providing competition where we have a mandate," Woodcock said. Separately, the FDA is seeking feedback on a proposal to charge a fee before a biosimilar is reviewed.

View Full Article in:

Reuters · Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX